Related references
Note: Only part of the references are listed.Cost effectiveness of teriparatide and PTH(1-84) in the treatment of postmenopausal osteoporosis
Fredrik Borgström et al.
JOURNAL OF MEDICAL ECONOMICS (2010)
Reduction in Fracture Rate and Back Pain and Increased Quality of Life in Postmenopausal Women Treated with Teriparatide: 18-Month Data from the European Forsteo Observational Study (EFOS)
Bente L. Langdahl et al.
CALCIFIED TISSUE INTERNATIONAL (2009)
An updated systematic review of Health State Utility Values for osteoporosis related conditions
T. Peasgood et al.
OSTEOPOROSIS INTERNATIONAL (2009)
European guidance for the diagnosis and management of osteoporosis in postmenopausal women
J. A. Kanis et al.
OSTEOPOROSIS INTERNATIONAL (2008)
Teriparatide or alendronate in glucocorticoid-induced osteoporosis
Kenneth G. Saag et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
The societal burden of osteoporosis in Sweden
Fredrik Borgstrom et al.
BONE (2007)
Compliance with drug therapy for postmenopausal osteoporosis
D. Weycker et al.
OSTEOPOROSIS INTERNATIONAL (2006)
Economic evaluation of parathyroid hormone (PTH) in the treatment of osteoporosis in postmenopausal women
J Lundkvist et al.
OSTEOPOROSIS INTERNATIONAL (2006)
Prevention and treatment of glucocorticoid-induced osteoporosis in 2005
P Orcel
JOINT BONE SPINE (2005)
Sustained nonvertebral fragility fracture risk reduction after discontinuation of teriparatide treatment
R Prince et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2005)
The effects of teriparatide on the incidence of back pain in postmenopausal women with osteoporosis
HK Genant et al.
CURRENT MEDICAL RESEARCH AND OPINION (2005)
Cost-effectiveness of alendronate therapy for osteopenic postmenopausal women
JT Schousboe et al.
ANNALS OF INTERNAL MEDICINE (2005)
Quality of life in patients with osteoporosis
P Lips et al.
OSTEOPOROSIS INTERNATIONAL (2005)
Cost-effectiveness of raloxifene in the UK: an economic evaluation based on the MORE study
JA Kanis et al.
OSTEOPOROSIS INTERNATIONAL (2005)
Mortality after osteoporotic fractures
O Johnell et al.
OSTEOPOROSIS INTERNATIONAL (2004)
Sustained vertebral fracture risk reduction after withdrawal of teriparatide in postmenopausal women with osteoporosis
R Lindsay et al.
ARCHIVES OF INTERNAL MEDICINE (2004)
The components of excess mortality after hip fracture
JA Kanis et al.
BONE (2003)
Glucocorticoid-induced osteoporosis
KG Saag
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2003)
Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis.
RM Neer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Oral corticosteroids and fracture risk: relationship to daily and cumulative doses
TP van Staa et al.
RHEUMATOLOGY (2000)
Long-term risk of osteoporotic fracture in Malmo
JA Kanis et al.
OSTEOPOROSIS INTERNATIONAL (2000)
Share Paper
